Thyroid Gland Disorder Treatment
Thyroid Gland Disorder Treatment

Thyroid Gland Disorder Treatment Comprehensive Study by Type (Medication, Surgery), Application (Men, Women), Diagnosis (Blood Tests, Imaging Tests, Physical Exams), Disorder Type (Hypothyroidism, Hyperthyroidism, Goiter, Thyroid Nodules, Thyroid Cancer) Players and Region - Global Market Outlook to 2026

Thyroid Gland Disorder Treatment Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 208 Pages 163 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Thyroid Gland Disorder Treatment Market?

The thyroid is a small organ located in the front of the neck that is wrapped around the windpipe (windpipe). It is in the shape of a butterfly, is smaller in the middle, and has two broad wings that extend around the side of your neck. The thyroid is a gland. There are various glands present all over the body where they create and release substances that help the body do a certain thing. The thyroid gland produces hormones that help control many of the body's vital functions. When the thyroid gland is not working properly, it can affect the entire body. If the body makes too much thyroid hormone, there are chances of developing a condition called hyperthyroidism. If the body does not produce enough thyroid hormone, it is known as hypothyroidism. Both conditions are serious and should be treated by a doctor. Thyroid disease can be treated with medication or, in some cases, with surgery. Treatment will vary depending on the type of thyroid disease. If thyroid hormones are high (hyperthyroidism), treatment options may include thyroid drugs (methimazole and propylthiouracil), radioactive iodine, beta-blockers, and surgery. If the thyroid hormone levels are low (hypothyroidism), the main treatment option is a thyroid replacement drug that allows adding thyroid hormones back into the body. A commonly used drug is called levothyroxine. Surgery can be used to remove a large goiter or an over-functioning lump within the gland. Surgery is required if there is a possibility of thyroid cancer.

The market study is being classified by Type (Medication and Surgery), by Application (Men and Women) and major geographies with country level break-up.

Abbott Laboratories (United States), RLC Labs, Inc. (United States), Allergan plc (Ireland), Merck & Co. (United States), AbbVie Inc. (United States), Pfizer Inc. (United States), Lannett Co. Inc. (United States), Mylan N.V. (United States), GlaxoSmithKline plc (United Kingdom), Novartis AG (Switzerland), Takeda Pharmaceutical Company Limited (Japan), Aspen Pharmacare (South Africa) and Amgen Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Endo International plc (Ireland), Acella Pharmaceuticals, LLC (United States) and Gemini Laboratories, LLC (United States).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Thyroid Gland Disorder Treatment market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Thyroid Gland Disorder Treatment market by Type, Application and Region.

On the basis of geography, the market of Thyroid Gland Disorder Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in the Incidence of Thyroid Gland Disorder
  • Growing Awareness Levels among Individuals
  • Sedentary Lifestyle and Consistent Expanding Pool of Geriatric Population
  • Rise In the Number of Disease Awareness Programs Especially In the Developing Countries

Market Trend
  • High Efficacy, a Higher Rate of Bioavailability, And Rapid Delivery of Drugs Are Expected To Propel Segment Growth
  • Development of Effective Combination Drug Therapies to Treat Thyroid Gland Disorder

Restraints
  • Side Effects of the Drugs and Stringent Government Regulations

Opportunities
  • A Rise in Collaborations with Government Organizations to Spread Awareness Regarding Disease Management
  • Growth in Investments by the Market Incumbents

Challenges
  • Availability of Large Pool of Undiagnosed Patients Due To Asymptomatic Nature of Thyroid Disorders


In May 2017, Merck had thereby announced that it would support the 9th International Thyroid Awareness Week (ITAW). These forms of efforts are thus anticipated to propel the demand for treatments near future.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Thyroid Gland Disorder Treatment, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Medication
  • Surgery
By Application
  • Men
  • Women
By Diagnosis
  • Blood Tests
  • Imaging Tests
  • Physical Exams

By Disorder Type
  • Hypothyroidism
  • Hyperthyroidism
  • Goiter
  • Thyroid Nodules
  • Thyroid Cancer

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Incidence of Thyroid Gland Disorder
      • 3.2.2. Growing Awareness Levels among Individuals
      • 3.2.3. Sedentary Lifestyle and Consistent Expanding Pool of Geriatric Population
      • 3.2.4. Rise In the Number of Disease Awareness Programs Especially In the Developing Countries
    • 3.3. Market Challenges
      • 3.3.1. Availability of Large Pool of Undiagnosed Patients Due To Asymptomatic Nature of Thyroid Disorders
    • 3.4. Market Trends
      • 3.4.1. High Efficacy, a Higher Rate of Bioavailability, And Rapid Delivery of Drugs Are Expected To Propel Segment Growth
      • 3.4.2. Development of Effective Combination Drug Therapies to Treat Thyroid Gland Disorder
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Thyroid Gland Disorder Treatment, by Type, Application, Diagnosis, Disorder Type and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Thyroid Gland Disorder Treatment (Value)
      • 5.2.1. Global Thyroid Gland Disorder Treatment by: Type (Value)
        • 5.2.1.1. Medication
        • 5.2.1.2. Surgery
      • 5.2.2. Global Thyroid Gland Disorder Treatment by: Application (Value)
        • 5.2.2.1. Men
        • 5.2.2.2. Women
      • 5.2.3. Global Thyroid Gland Disorder Treatment by: Diagnosis (Value)
        • 5.2.3.1. Blood Tests
        • 5.2.3.2. Imaging Tests
        • 5.2.3.3. Physical Exams
      • 5.2.4. Global Thyroid Gland Disorder Treatment by: Disorder Type (Value)
        • 5.2.4.1. Hypothyroidism
        • 5.2.4.2. Hyperthyroidism
        • 5.2.4.3. Goiter
        • 5.2.4.4. Thyroid Nodules
        • 5.2.4.5. Thyroid Cancer
      • 5.2.5. Global Thyroid Gland Disorder Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Thyroid Gland Disorder Treatment (Price)
      • 5.3.1. Global Thyroid Gland Disorder Treatment by: Type (Price)
  • 6. Thyroid Gland Disorder Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. RLC Labs, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allergan plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AbbVie Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lannett Co. Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mylan N.V. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GlaxoSmithKline plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Novartis AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Takeda Pharmaceutical Company Limited (Japan)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Aspen Pharmacare (South Africa)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Amgen Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Thyroid Gland Disorder Treatment Sale, by Type, Application, Diagnosis, Disorder Type and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Thyroid Gland Disorder Treatment (Value)
      • 7.2.1. Global Thyroid Gland Disorder Treatment by: Type (Value)
        • 7.2.1.1. Medication
        • 7.2.1.2. Surgery
      • 7.2.2. Global Thyroid Gland Disorder Treatment by: Application (Value)
        • 7.2.2.1. Men
        • 7.2.2.2. Women
      • 7.2.3. Global Thyroid Gland Disorder Treatment by: Diagnosis (Value)
        • 7.2.3.1. Blood Tests
        • 7.2.3.2. Imaging Tests
        • 7.2.3.3. Physical Exams
      • 7.2.4. Global Thyroid Gland Disorder Treatment by: Disorder Type (Value)
        • 7.2.4.1. Hypothyroidism
        • 7.2.4.2. Hyperthyroidism
        • 7.2.4.3. Goiter
        • 7.2.4.4. Thyroid Nodules
        • 7.2.4.5. Thyroid Cancer
      • 7.2.5. Global Thyroid Gland Disorder Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Thyroid Gland Disorder Treatment (Price)
      • 7.3.1. Global Thyroid Gland Disorder Treatment by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Thyroid Gland Disorder Treatment: by Type(USD Million)
  • Table 2. Thyroid Gland Disorder Treatment Medication , by Region USD Million (2015-2020)
  • Table 3. Thyroid Gland Disorder Treatment Surgery , by Region USD Million (2015-2020)
  • Table 4. Thyroid Gland Disorder Treatment: by Application(USD Million)
  • Table 5. Thyroid Gland Disorder Treatment Men , by Region USD Million (2015-2020)
  • Table 6. Thyroid Gland Disorder Treatment Women , by Region USD Million (2015-2020)
  • Table 7. Thyroid Gland Disorder Treatment: by Diagnosis(USD Million)
  • Table 8. Thyroid Gland Disorder Treatment Blood Tests , by Region USD Million (2015-2020)
  • Table 9. Thyroid Gland Disorder Treatment Imaging Tests , by Region USD Million (2015-2020)
  • Table 10. Thyroid Gland Disorder Treatment Physical Exams , by Region USD Million (2015-2020)
  • Table 11. Thyroid Gland Disorder Treatment: by Disorder Type(USD Million)
  • Table 12. Thyroid Gland Disorder Treatment Hypothyroidism , by Region USD Million (2015-2020)
  • Table 13. Thyroid Gland Disorder Treatment Hyperthyroidism , by Region USD Million (2015-2020)
  • Table 14. Thyroid Gland Disorder Treatment Goiter , by Region USD Million (2015-2020)
  • Table 15. Thyroid Gland Disorder Treatment Thyroid Nodules , by Region USD Million (2015-2020)
  • Table 16. Thyroid Gland Disorder Treatment Thyroid Cancer , by Region USD Million (2015-2020)
  • Table 17. South America Thyroid Gland Disorder Treatment, by Country USD Million (2015-2020)
  • Table 18. South America Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 19. South America Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 20. South America Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 21. South America Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 22. Brazil Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 23. Brazil Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 24. Brazil Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 25. Brazil Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 26. Argentina Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 27. Argentina Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 28. Argentina Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 29. Argentina Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 30. Rest of South America Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 33. Rest of South America Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 34. Asia Pacific Thyroid Gland Disorder Treatment, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 38. Asia Pacific Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 39. China Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 40. China Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 41. China Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 42. China Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 43. Japan Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 44. Japan Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 45. Japan Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 46. Japan Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 47. India Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 48. India Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 49. India Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 50. India Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 51. South Korea Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 52. South Korea Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 53. South Korea Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 54. South Korea Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 55. Taiwan Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 56. Taiwan Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 57. Taiwan Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 58. Taiwan Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 59. Australia Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 60. Australia Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 61. Australia Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 62. Australia Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 67. Europe Thyroid Gland Disorder Treatment, by Country USD Million (2015-2020)
  • Table 68. Europe Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 69. Europe Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 70. Europe Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 71. Europe Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 72. Germany Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 73. Germany Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 74. Germany Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 75. Germany Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 76. France Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 77. France Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 78. France Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 79. France Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 80. Italy Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 81. Italy Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 82. Italy Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 83. Italy Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 84. United Kingdom Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 87. United Kingdom Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 88. Netherlands Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 89. Netherlands Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 90. Netherlands Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 91. Netherlands Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 92. Rest of Europe Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 95. Rest of Europe Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 96. MEA Thyroid Gland Disorder Treatment, by Country USD Million (2015-2020)
  • Table 97. MEA Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 98. MEA Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 99. MEA Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 100. MEA Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 101. Middle East Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 102. Middle East Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 103. Middle East Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 104. Middle East Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 105. Africa Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 106. Africa Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 107. Africa Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 108. Africa Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 109. North America Thyroid Gland Disorder Treatment, by Country USD Million (2015-2020)
  • Table 110. North America Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 111. North America Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 112. North America Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 113. North America Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 114. United States Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 115. United States Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 116. United States Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 117. United States Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 118. Canada Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 119. Canada Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 120. Canada Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 121. Canada Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 122. Mexico Thyroid Gland Disorder Treatment, by Type USD Million (2015-2020)
  • Table 123. Mexico Thyroid Gland Disorder Treatment, by Application USD Million (2015-2020)
  • Table 124. Mexico Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2015-2020)
  • Table 125. Mexico Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2015-2020)
  • Table 126. Thyroid Gland Disorder Treatment: by Type(USD/Units)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Thyroid Gland Disorder Treatment: by Type(USD Million)
  • Table 141. Thyroid Gland Disorder Treatment Medication , by Region USD Million (2021-2026)
  • Table 142. Thyroid Gland Disorder Treatment Surgery , by Region USD Million (2021-2026)
  • Table 143. Thyroid Gland Disorder Treatment: by Application(USD Million)
  • Table 144. Thyroid Gland Disorder Treatment Men , by Region USD Million (2021-2026)
  • Table 145. Thyroid Gland Disorder Treatment Women , by Region USD Million (2021-2026)
  • Table 146. Thyroid Gland Disorder Treatment: by Diagnosis(USD Million)
  • Table 147. Thyroid Gland Disorder Treatment Blood Tests , by Region USD Million (2021-2026)
  • Table 148. Thyroid Gland Disorder Treatment Imaging Tests , by Region USD Million (2021-2026)
  • Table 149. Thyroid Gland Disorder Treatment Physical Exams , by Region USD Million (2021-2026)
  • Table 150. Thyroid Gland Disorder Treatment: by Disorder Type(USD Million)
  • Table 151. Thyroid Gland Disorder Treatment Hypothyroidism , by Region USD Million (2021-2026)
  • Table 152. Thyroid Gland Disorder Treatment Hyperthyroidism , by Region USD Million (2021-2026)
  • Table 153. Thyroid Gland Disorder Treatment Goiter , by Region USD Million (2021-2026)
  • Table 154. Thyroid Gland Disorder Treatment Thyroid Nodules , by Region USD Million (2021-2026)
  • Table 155. Thyroid Gland Disorder Treatment Thyroid Cancer , by Region USD Million (2021-2026)
  • Table 156. South America Thyroid Gland Disorder Treatment, by Country USD Million (2021-2026)
  • Table 157. South America Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 158. South America Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 159. South America Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 160. South America Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 161. Brazil Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 162. Brazil Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 163. Brazil Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 164. Brazil Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 165. Argentina Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 166. Argentina Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 167. Argentina Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 168. Argentina Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 169. Rest of South America Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 170. Rest of South America Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 171. Rest of South America Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 172. Rest of South America Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 173. Asia Pacific Thyroid Gland Disorder Treatment, by Country USD Million (2021-2026)
  • Table 174. Asia Pacific Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 175. Asia Pacific Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 176. Asia Pacific Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 177. Asia Pacific Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 178. China Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 179. China Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 180. China Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 181. China Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 182. Japan Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 183. Japan Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 184. Japan Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 185. Japan Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 186. India Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 187. India Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 188. India Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 189. India Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 190. South Korea Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 191. South Korea Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 192. South Korea Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 193. South Korea Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 194. Taiwan Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 195. Taiwan Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 196. Taiwan Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 197. Taiwan Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 198. Australia Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 199. Australia Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 200. Australia Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 201. Australia Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 206. Europe Thyroid Gland Disorder Treatment, by Country USD Million (2021-2026)
  • Table 207. Europe Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 208. Europe Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 209. Europe Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 210. Europe Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 211. Germany Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 212. Germany Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 213. Germany Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 214. Germany Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 215. France Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 216. France Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 217. France Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 218. France Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 219. Italy Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 220. Italy Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 221. Italy Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 222. Italy Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 223. United Kingdom Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 224. United Kingdom Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 225. United Kingdom Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 226. United Kingdom Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 227. Netherlands Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 228. Netherlands Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 229. Netherlands Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 230. Netherlands Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 231. Rest of Europe Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 232. Rest of Europe Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 233. Rest of Europe Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 234. Rest of Europe Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 235. MEA Thyroid Gland Disorder Treatment, by Country USD Million (2021-2026)
  • Table 236. MEA Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 237. MEA Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 238. MEA Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 239. MEA Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 240. Middle East Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 241. Middle East Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 242. Middle East Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 243. Middle East Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 244. Africa Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 245. Africa Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 246. Africa Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 247. Africa Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 248. North America Thyroid Gland Disorder Treatment, by Country USD Million (2021-2026)
  • Table 249. North America Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 250. North America Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 251. North America Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 252. North America Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 253. United States Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 254. United States Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 255. United States Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 256. United States Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 257. Canada Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 258. Canada Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 259. Canada Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 260. Canada Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 261. Mexico Thyroid Gland Disorder Treatment, by Type USD Million (2021-2026)
  • Table 262. Mexico Thyroid Gland Disorder Treatment, by Application USD Million (2021-2026)
  • Table 263. Mexico Thyroid Gland Disorder Treatment, by Diagnosis USD Million (2021-2026)
  • Table 264. Mexico Thyroid Gland Disorder Treatment, by Disorder Type USD Million (2021-2026)
  • Table 265. Thyroid Gland Disorder Treatment: by Type(USD/Units)
  • Table 266. Research Programs/Design for This Report
  • Table 267. Key Data Information from Secondary Sources
  • Table 268. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Thyroid Gland Disorder Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Thyroid Gland Disorder Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Thyroid Gland Disorder Treatment: by Diagnosis USD Million (2015-2020)
  • Figure 7. Global Thyroid Gland Disorder Treatment: by Disorder Type USD Million (2015-2020)
  • Figure 8. South America Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 9. Asia Pacific Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 10. Europe Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 11. MEA Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 12. North America Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 13. Global Thyroid Gland Disorder Treatment: by Type USD/Units (2015-2020)
  • Figure 14. Global Thyroid Gland Disorder Treatment share by Players 2020 (%)
  • Figure 15. Global Thyroid Gland Disorder Treatment share by Players (Top 3) 2020(%)
  • Figure 16. Global Thyroid Gland Disorder Treatment share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 20. RLC Labs, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. RLC Labs, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Allergan plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. Allergan plc (Ireland) Revenue: by Geography 2020
  • Figure 24. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck & Co. (United States) Revenue: by Geography 2020
  • Figure 26. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. AbbVie Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Lannett Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Lannett Co. Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 34. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 36. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 38. Takeda Pharmaceutical Company Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 39. Takeda Pharmaceutical Company Limited (Japan) Revenue: by Geography 2020
  • Figure 40. Aspen Pharmacare (South Africa) Revenue, Net Income and Gross profit
  • Figure 41. Aspen Pharmacare (South Africa) Revenue: by Geography 2020
  • Figure 42. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 43. Amgen Inc. (United States) Revenue: by Geography 2020
  • Figure 44. Global Thyroid Gland Disorder Treatment: by Type USD Million (2021-2026)
  • Figure 45. Global Thyroid Gland Disorder Treatment: by Application USD Million (2021-2026)
  • Figure 46. Global Thyroid Gland Disorder Treatment: by Diagnosis USD Million (2021-2026)
  • Figure 47. Global Thyroid Gland Disorder Treatment: by Disorder Type USD Million (2021-2026)
  • Figure 48. South America Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 49. Asia Pacific Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 50. Europe Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 51. MEA Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 52. North America Thyroid Gland Disorder Treatment Share (%), by Country
  • Figure 53. Global Thyroid Gland Disorder Treatment: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • RLC Labs, Inc. (United States)
  • Allergan plc (Ireland)
  • Merck & Co. (United States)
  • AbbVie Inc. (United States)
  • Pfizer Inc. (United States)
  • Lannett Co. Inc. (United States)
  • Mylan N.V. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Novartis AG (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Aspen Pharmacare (South Africa)
  • Amgen Inc. (United States)
Additional players considered in the study are as follows:
Endo International plc (Ireland) , Acella Pharmaceuticals, LLC (United States) , Gemini Laboratories, LLC (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation